Ying-Chung Hong

706 total citations
20 papers, 534 citations indexed

About

Ying-Chung Hong is a scholar working on Pathology and Forensic Medicine, Hematology and Genetics. According to data from OpenAlex, Ying-Chung Hong has authored 20 papers receiving a total of 534 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pathology and Forensic Medicine, 8 papers in Hematology and 6 papers in Genetics. Recurrent topics in Ying-Chung Hong's work include Lymphoma Diagnosis and Treatment (8 papers), Multiple Myeloma Research and Treatments (4 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Ying-Chung Hong is often cited by papers focused on Lymphoma Diagnosis and Treatment (8 papers), Multiple Myeloma Research and Treatments (4 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Ying-Chung Hong collaborates with scholars based in Taiwan and United States. Ying-Chung Hong's co-authors include Cheng‐Hwai Tzeng, Tzeon-Jye Chiou, Liang-Tsai Hsiao, Jyh-Pyng Gau, Chun‐Yu Liu, Yuan-Bin Yu, Han‐Chieh Lin, Shou‐Dong Lee, Yi‐Hsiang Huang and Muh‐Hwa Yang and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Cancer and Thrombosis and Haemostasis.

In The Last Decade

Ying-Chung Hong

20 papers receiving 527 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ying-Chung Hong Taiwan 10 265 202 134 131 68 20 534
Luca Pezzullo Italy 10 159 0.6× 202 1.0× 66 0.5× 26 0.2× 131 1.9× 35 469
Elisa Anselmi Italy 10 98 0.4× 130 0.6× 219 1.6× 131 1.0× 21 0.3× 30 496
Carlo Moroni Italy 8 92 0.3× 135 0.7× 135 1.0× 145 1.1× 30 0.4× 17 340
Hee Ho Chu South Korea 15 229 0.9× 353 1.7× 77 0.6× 61 0.5× 27 0.4× 79 792
Olga Trejo Spain 12 212 0.8× 332 1.6× 49 0.4× 88 0.7× 91 1.3× 17 839
M Massazza Italy 5 372 1.4× 638 3.2× 41 0.3× 75 0.6× 45 0.7× 6 893
M C Anglade France 11 120 0.5× 206 1.0× 76 0.6× 60 0.5× 101 1.5× 17 638
Laniyati Hamijoyo Indonesia 11 80 0.3× 54 0.3× 87 0.6× 122 0.9× 55 0.8× 69 798
L. La Rosa Italy 7 74 0.3× 105 0.5× 25 0.2× 35 0.3× 123 1.8× 14 605
Shintaro Shirai Japan 15 123 0.5× 195 1.0× 70 0.5× 38 0.3× 9 0.1× 41 566

Countries citing papers authored by Ying-Chung Hong

Since Specialization
Citations

This map shows the geographic impact of Ying-Chung Hong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ying-Chung Hong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ying-Chung Hong more than expected).

Fields of papers citing papers by Ying-Chung Hong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ying-Chung Hong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ying-Chung Hong. The network helps show where Ying-Chung Hong may publish in the future.

Co-authorship network of co-authors of Ying-Chung Hong

This figure shows the co-authorship network connecting the top 25 collaborators of Ying-Chung Hong. A scholar is included among the top collaborators of Ying-Chung Hong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ying-Chung Hong. Ying-Chung Hong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tan, Tran‐Der, et al.. (2020). Lenalidomide with Dexamethasone to Multiple Myeloma Patients Relapsing from Bortezomib-Based Induction Therapies. The Chinese Journal of Physiology. 63(5). 211–217. 2 indexed citations
2.
Yeh, Chiu-Mei, Yu‐Ting Lee, Liang-Tsai Hsiao, et al.. (2020). Risk and impact of invasive fungal infections in patients with multiple myeloma. Annals of Hematology. 99(8). 1813–1822. 18 indexed citations
3.
4.
Chien, Sheng‐Hsuan, Chia‐Jen Liu, Ying-Chung Hong, et al.. (2015). Development of second primary malignancy in patients with non-Hodgkin lymphoma: a nationwide population-based study. Journal of Cancer Research and Clinical Oncology. 141(11). 1995–2004. 23 indexed citations
5.
Chien, Sheng‐Hsuan, Chia‐Jen Liu, Yu‐Wen Hu, et al.. (2015). Frequency of surveillance computed tomography in non-Hodgkin lymphoma and the risk of secondary primary malignancies: A nationwide population-based study. International Journal of Cancer. 137(3). 658–665. 34 indexed citations
6.
Lu, Dai-Yin, Jyh-Pyng Gau, Ying-Chung Hong, et al.. (2014). Mast cell leukemia: An extremely rare disease. Journal of the Chinese Medical Association. 77(8). 446–449. 1 indexed citations
7.
Gau, Jyh-Pyng, Yuan-Bin Yu, Ying-Chung Hong, et al.. (2014). Prognostic Factors and Treatment Efficacy in Patients with Primary Diffuse Large B-cell Lymphoma of the Bone: Single Institute Experience Over 11 Years. Internal Medicine. 53(2). 95–101. 14 indexed citations
8.
Liu, Chun‐Yu, Hsueh‐Ju Lu, Man‐Hsin Hung, et al.. (2013). Comparison of prognostic models for patients with diffuse large B-cell lymphoma in the rituximab era. Annals of Hematology. 92(11). 1513–1520. 15 indexed citations
9.
Huang, Yi‐Hsiang, Liang-Tsai Hsiao, Ying-Chung Hong, et al.. (2013). Randomized Controlled Trial of Entecavir Prophylaxis for Rituximab-Associated Hepatitis B Virus Reactivation in Patients With Lymphoma and Resolved Hepatitis B. Journal of Clinical Oncology. 31(22). 2765–2772. 243 indexed citations
10.
Lu, Hsueh‐Ju, Chun‐Yu Liu, Man‐Hsin Hung, et al.. (2013). Diminishing prognostic role of preexisting diabetes mellitus for patients with diffuse large B-cell lymphoma in the rituximab era. Annals of Hematology. 92(11). 1495–1501. 5 indexed citations
11.
Hung, Man‐Hsin, Yuan-Bin Yu, Liang-Tsai Hsiao, et al.. (2013). Absolute lymphocyte count predicts response to rituximab-containing salvage treatment for relapsed/refractory B-cell non-Hodgkin's lymphoma with prior rituximab exposure. Journal of the Chinese Medical Association. 76(4). 195–200. 3 indexed citations
12.
13.
Liu, Chun‐Yu, Muh‐Hwa Yang, Hui-Chi Hsu, et al.. (2012). A nation-wide analysis of venous thromboembolism in 497,180 cancer patients with the development and validation of a risk-stratification scoring system. Thrombosis and Haemostasis. 108(8). 225–235. 90 indexed citations
14.
Gau, Jyh-Pyng, Ying-Chung Hong, Yuan-Bin Yu, et al.. (2012). Large pericardial effusion as a life-threatening complication after hematopoietic stem cell transplantation—association with chronic GVHD in late-onset adult patients. Annals of Hematology. 91(12). 1953–1958. 14 indexed citations
15.
Liu, Chia‐Jen, Ying-Chung Hong, Shih-Hao Liu, et al.. (2011). Clinicopathologic features and outcome of acute erythroid leukemia based on 2008 revised World Health Organization classification. Leukemia & lymphoma. 53(2). 289–294. 6 indexed citations
16.
Teng, Hao‐Wei, Ying-Chung Hong, Chun‐Yu Liu, et al.. (2011). International Staging System predicts prognosis of Chinese patients with multiple myeloma across different calendar periods with application of novel agents. Annals of Hematology. 91(1). 93–102. 5 indexed citations
17.
Lin, Yen‐Chung & Ying-Chung Hong. (2011). Myelomatous Orbital and Intracranial Involvement. The American Journal of the Medical Sciences. 342(2). 169–169. 1 indexed citations
18.
Liu, Chia‐Jen, Chun‐Yu Liu, Ying-Chung Hong, et al.. (2011). Low absolute lymphocyte count and addition of rituximab confer high risk for interstitial pneumonia in patients with diffuse large B-cell lymphoma. Annals of Hematology. 90(10). 1145–1151. 32 indexed citations
19.
Hong, Ying-Chung, Liang-Tsai Hsiao, Yuan-Bin Yu, et al.. (2010). Effect of allogeneic hematopoietic stem cell transplantation from matched siblings or unrelated donors during the first complete remission in patients with cytogenetically normal acute myeloid leukemia. European Journal Of Haematology. 86(3). 237–245. 3 indexed citations
20.
Liu, Chun‐Yu, Ying-Chung Hong, Yuan-Bin Yu, et al.. (2010). Clinical features and prognostic factors of angioimmunoblastic T-cell lymphoma in Taiwan: a single-institution experience. Leukemia & lymphoma. 51(12). 2208–2214. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Luca Pezzullo Breakdown of academic impact, for papers by Elisa Anselmi Breakdown of academic impact, for papers by Carlo Moroni Breakdown of academic impact, for papers by Hee Ho Chu Breakdown of academic impact, for papers by Olga Trejo Breakdown of academic impact, for papers by M Massazza Breakdown of academic impact, for papers by M C Anglade Breakdown of academic impact, for papers by Laniyati Hamijoyo Breakdown of academic impact, for papers by L. La Rosa Breakdown of academic impact, for papers by Shintaro Shirai
Rankless by CCL
2026